I thought there was. #1. But doesn’t specify num

I thought there was. #1. But doesn’t specify number of days.

This from clinical trials website.

Exclusion Criteria:
Subjects showing signs of severe pneumonia, acute respiratory distress syndrome (ARDS) or respiratory failure necessitating mechanical ventilation during the course of their COVID-19 illness;
History of moderate or severe chronic respiratory disease (such as COPD or asthma) and requirement for long-term oxygen therapy;
Patient with pulse oxygen saturation (SpO2) of <94% on room air at the time of screening
History of pulmonary embolus or deep venous thrombosis within the past year
History of splenectomy
History of chronic liver disease or patient showing signs of clinical jaundice at the time of screening
History of severe chronic kidney disease or requiring dialysis at the time of screening
Patient with NYHA Class III or IV congestive heart failure (CHF)
Patient with uncontrolled rheumatologic disorders at the time of screening
Patients with a history of organ transplantation or are candidates for organ transplantation at the time of screening
Patients with underlying chronic viral or bacterium illnesses including hepatitis of any kind, HIV, Epstein-Barr virus (EBV), chronic Lyme disease
No history of Chronic Fatigue Syndrome prior to COVID-19 infection
No history of fibromyalgia prior to COVID-19 infection
Patients with malignant tumor, or other serious systemic diseases
Treatment with any of the following:
Hydroxychloroquine, oral or parenteral corticosteroids, immunosuppressants, or immunomodulating agents within 7 days prior to the screening visit
Albuterol as nebulizer for the off-label treatment of COVID-19 within 7 days prior to the screening visit
Subjects who have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to leronlimab (PRO 140) are not eligible
Inability to provide informed consent or to comply with test requirements
Consideration by the investigator, for safety reasons, that the subject is an unsuitable candidate to receive study treatment
Pregnancy or breast feeding
Subject participating in another study with for an investigational treatment for COVID-19